VISEN Pharmaceuticals (HKG:2561)
Hong Kong · Delayed Price · Currency is HKD 20.00
0.00 (0.00%)
Aug 27, 2026, 1:29 PM HKT
VISEN Pharmaceuticals Market Cap
VISEN Pharmaceuticals has a market cap or net worth of 2.18 billion as of August 26, 2026. Its market cap has decreased by -54.67% in one year.
Market Cap
2.18B
Enterprise Value
1.67B
Revenue
151.34K
Ranking
n/a
PE Ratio
n/a
Stock Price
20.00
ChartMarket Cap Chart
Since March 21, 2025, VISEN Pharmaceuticals's market cap has decreased from 7.20B to 2.18B, a decrease of -69.69%. That is a compound annual growth rate of -56.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 2.18B | -36.69% |
| Dec 31, 2025 | 3.44B | -52.13% |
| Mar 21, 2025 | 7.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xuanzhu Biopharmaceutical | 5.73B |
| Beijing Tong Ren Tang Chinese Medicine Company | 5.35B |
| Edding Genor Group Holdings | 3.17B |
| Hua Medicine (Shanghai) | 2.59B |
| CPBIO Holding Company | 2.21B |
| Jacobson Pharma Corporation | 2.10B |
| Golden Throat Holdings Group Company | 1.84B |
| JBM (Healthcare) | 1.57B |